Wednesday, June 10, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 39 of 1,261
  1. US 12319916

    Modulation of gene transcription using antisense oligonucleotides targeting regulatory RNAs

    CAMP4 Therapeutics Corporation · Granted Jun 3, 2025 · Expires May 29, 2045

    granted
  2. US 12318362

    Methods of providing solriamfetol therapy to subjects with impaired renal function

    AXSOME MALTA LTD. · Granted Jun 3, 2025 · Expires May 29, 2045

    granted
  3. US 12319703

    Macrocyclic fused pyrazoles as Mcl-1 inhibitors

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jun 3, 2025 · Expires May 29, 2045

    granted
  4. US 12319929

    Compositions and methods for the treatment of Parkinson's disease

    VOYAGER THERAPEUTICS, INC. · Granted Jun 3, 2025 · Expires May 29, 2045

    granted
  5. US 12318427

    Methods and compositions for modulation of tau proteins

    Sangamo Therapeutics, Inc. · Granted Jun 3, 2025 · Expires May 29, 2045

    granted
  6. US 12319940

    Methods for purification of arylsulfatase A

    Takeda Pharmaceutical Company Limited · Granted Jun 3, 2025 · Expires May 29, 2045

    granted
  7. US 12318487

    Solid tablet dosage form of ridinilazole

    SUMMIT (OXFORD) LIMITED · Granted Jun 3, 2025 · Expires May 29, 2045

    granted
  8. US 12318454

    Bicyclic peptide ligands specific for MT1-MMP

    BicycleRD Limited · Granted Jun 3, 2025 · Expires May 29, 2045

    granted
  9. US 12318426

    Compositions and methods for the treatment of metabolic and liver disorders

    Viking Therapeutics, Inc. · Granted Jun 3, 2025 · Expires May 29, 2045

    granted
  10. US 12319748

    Antibody binding to human HER2 and preparation method and use thereof

    SUNSHINE GUOJIAN PHARMACEUTICAL (SHANGHAI) CO., LTD. · Granted Jun 3, 2025 · Expires May 29, 2045

    granted
  11. US 12319740

    Methods for production of tissue resident memory-like T cells and use thereof

    The Board of Regents of the University of Texas System · Granted Jun 3, 2025 · Expires May 29, 2045

    granted
  12. US 12318397

    Methods and compositions for testosterone production

    Maximus Health, Inc. · Granted Jun 3, 2025 · Expires May 29, 2045

    granted
  13. US 12318386

    Combination of XPO1 inhibitors and second agents for the treatment of prostate cancer

    Karyopharm Therapeutics Inc. · Granted Jun 3, 2025 · Expires May 29, 2045

    granted
  14. US 12318376

    Compositions of a polyorthoester and an aprotic solvent

    Heron Therapeutics, Inc. · Granted Jun 3, 2025 · Expires May 29, 2045

    granted
  15. US 12318439

    Attenuating viral mutations in protein genes

    The Board of Regents of the University of Texas System · Granted Jun 3, 2025 · Expires May 29, 2045

    granted
  16. US 12318418

    Modified adenoviruses

    University College Cardiff Consultants Limited · Granted Jun 3, 2025 · Expires May 29, 2045

    granted
  17. US 12318364

    Isoflavonoid compositions and methods for the treatment of cancer

    Aardvark Therapeutics, Inc. · Granted Jun 3, 2025 · Expires May 29, 2045

    granted
  18. US 12318356

    Use of cannabinoids in the treatment of epilepsy

    JAZZ PHARMACEUTICALS RESEARCH UK LIMITED · Granted Jun 3, 2025 · Expires May 29, 2045

    granted
  19. US 12318413

    Methods for enhancing immune checkpoint blockade therapy by modulating the microbiome

    The Board of Regents of the University of Texas System · Granted Jun 3, 2025 · Expires May 29, 2045

    granted
  20. US 12319752

    Heparin-binding cationic peptide self-assembling peptide amphiphiles useful against drug-resistant bacteria

    Northwestern University · Granted Jun 3, 2025 · Expires May 29, 2045

    granted
  21. WO 2025111408

    COMPOSÉS POUR LE TRAITEMENT DE L'AMYOTROPHIE SPINALE ET DE LA MALADIE DE HUNTINGTON

    BIOGEN MA INC [US] · Granted May 30, 2025 · Expires May 25, 2045

    granted
  22. WO 2025111258

    COMPOSITIONS DE SÉROTYPE A DE NEUROTOXINE DE CLOSTRIDIUM BOTULINUM ET PROCÉDÉS DE FILTRATION AMÉLIORÉS

    ABBVIE INC [US] · Granted May 30, 2025 · Expires May 25, 2045

    granted
  23. WO 2025108443

    COMPOSÉS HÉTÉROCYCLIQUES ET COMPOSITIONS ASSOCIÉES, ET MÉTHODES DE TRAITEMENT CORRESPONDANTES

    BEIGENE SWITZERLAND GMBH [CH] · Granted May 30, 2025 · Expires May 25, 2045

    granted
  24. WO 2025111409

    COMPOSÉS HÉTÉROCYCLIQUES DE FORMULE (I) DESTINÉS À ÊTRE UTILISÉS DANS LE TRAITEMENT DE L'AMYOTROPHIE SPINALE PAR MODULATION DE L'ÉPISSAGE DE SMN2

    BIOGEN MA INC [US] · Granted May 30, 2025 · Expires May 25, 2045

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.